The potential move by Donald Trump and Attorney General Todd Blanche to reclassify medical marijuana from Schedule I to Schedule III could mark one of the most significant regulatory shifts in the history of the U.S. cannabis industry. For operators, investors, and lenders—especially those working with Upwise Capital—this change isn’t just symbolic. It has real implications for taxes, profitability, and access to financing.
Let’s break down what Schedule III means, how it impacts IRS Code 280E, and why this could unlock new opportunities for cannabis businesses.
Understanding the Shift: From Schedule I to Schedule III
Under the Controlled Substances Act, Schedule I drugs are considered to have no accepted medical use and a high potential for abuse. Cannabis has long been classified alongside substances like heroin and LSD despite widespread state-level legalization.
Reclassifying marijuana to Schedule III would acknowledge its accepted medical use and place it in a category alongside drugs like ketamine or certain anabolic steroids. While it would still be federally regulated, the shift dramatically changes how cannabis businesses are treated, especially from a tax perspective.
The Big One: Relief from 280E
What is 280E?
Section 280E of the Internal Revenue Code prohibits businesses that traffic in Schedule I or II substances from deducting ordinary business expenses. This has been a massive burden for cannabis operators.
Instead of being taxed on net income (revenue minus expenses), cannabis businesses are taxed on gross income with only the cost of goods sold (COGS) deductible.
What Changes Under Schedule III?
If cannabis is reclassified to Schedule III, 280E would no longer apply.
That’s a game-changer.
Operators would be able to deduct:
- Rent
- Payroll
- Marketing
- Administrative costs
- Interest expenses
Real-World Impact
For many operators, effective tax rates have ranged from 60% to 80% under 280E. Removing this restriction could:
- Immediately improve net margins
- Increase retained earnings
- Strengthen balance sheets
- Enhance valuations
For struggling operators, this could be the difference between survival and shutdown.
Tax Advantages: More Than Just Deductions
Beyond 280E relief, Schedule III classification opens the door to standard tax treatment:
1. Normalized Corporate Tax Structure
Cannabis businesses would finally be taxed like any other company, allowing for:
- Net operating loss (NOL) carryforwards
- Depreciation and amortization benefits
- Tax credits and incentives
2. Improved Cash Flow
With lower tax burdens, operators retain more cash—fueling:
- Expansion
- Hiring
- Inventory growth
- Debt repayment
3. Cleaner Financial Reporting
Without 280E distortions, financial statements become:
- More transparent
- Easier to audit
- More attractive to institutional investors
Recent Comments